Real-time enrollment status for this metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 2:51 PM UTC
| NCT Number | NCT07108114 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 70 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Solve Therapeutics |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of August 27, 2026: Clinical trial NCT07108114 is currently recruiting participants. This phase1 study for metastatic solid tumors is actively seeking new participants at 7 locations across the United States. The study is sponsored by Solve Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07108114 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07108114 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.